Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS.

Saved in:
Bibliographic Details
Title: Regional variability and genotypic and pharmacodynamic effects on PrP concentration in the CNS.
Authors: Mortberg MA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Zhao HT; Ionis Pharmaceuticals Inc., Carlsbad, California, USA., Reidenbach AG; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Gentile JE; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Kuhn E; Proteomics Platform, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA., O'Moore J; McLaughlin Research Institute, Great Falls, Montana, USA., Dooley PM; Massachusetts Alzheimer's Disease Research Center, and., Connors TR; Massachusetts Alzheimer's Disease Research Center, and., Mazur C; Ionis Pharmaceuticals Inc., Carlsbad, California, USA., Allen SW; McCance Center for Brain Health, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Trombetta BA; McCance Center for Brain Health, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., McManus A; McCance Center for Brain Health, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Moore MR; Bioagilytix, Boston, Massachusetts, USA., Liu J; Bioagilytix, Boston, Massachusetts, USA., Cabin DE; McLaughlin Research Institute, Great Falls, Montana, USA., Kordasiewicz HB; Ionis Pharmaceuticals Inc., Carlsbad, California, USA., Mathews J; Ionis Pharmaceuticals Inc., Carlsbad, California, USA., Arnold SE; McCance Center for Brain Health, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA., Vallabh SM; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; McCance Center for Brain Health, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Prion Alliance, Cambridge, Massachusetts, USA., Minikel EV; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; McCance Center for Brain Health, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Prion Alliance, Cambridge, Massachusetts, USA.
Source: JCI insight [JCI Insight] 2022 Mar 22; Vol. 7 (6). Date of Electronic Publication: 2022 Mar 22.
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.156532